Market Research Logo

Taiwan Pharmaceuticals & Healthcare Q1 2018

Taiwan Pharmaceuticals & Healthcare Q1 2018

BMI View: Like other developed markets, Taiwan offers considerable positives, including a strong preference for patented drugs, a mature chronic disease profile and hospitals as key points of healthcare access. However, its absolute values are relatively modest and remain at risk from authorities' attempts to control healthcare expenditure.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Taiwan 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Taiwan 2013-2021)
Healthcare Market Forecast
Table: Co-payments Levels (TWD)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Taiwan 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Taiwan 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Taiwan 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Taiwan 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Taiwan 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Taiwan 2015-2021)
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Diverse Opportunities And Inherent Risks
Regulatory Review
Table: Medicine Categories In Taiwan
Table: Examples Of Controlled Drugs In Taiwan
Intellectual Property Issues
Pricing & Reimbursement Regime
Table: Price Adjustments Enacted
Market Overview
Healthcare Sector
Table: NHI Premium Contribution Ratios
Table: Healthcare Resources (Taiwan 2011-2016)
Table: Healthcare Personnel (Taiwan 2011-2016)
Table: Healthcare Activity (Taiwan 2011-2016)
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Corporate Member Companies Of IRPMA
Table: Multinational Market Activity
Generic Drugmakers
Table: Members of Taiwan Generic Pharmaceutical Association (as of June 2016)
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
ScinoPharm Taiwan
TaiGen
Yung Shin Pharmaceutical
Demographic Forecast
Table: Population Headline Indicators (Taiwan 1990-2025)
Table: Key Population Ratios (Taiwan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Taiwan 1990-2025)
Table: Population By Age Group (Taiwan 1990-2025)
Table: Population By Age Group % (Taiwan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report